Target type: biologicalprocess
Any process involved in the maintenance of an internal steady state of magnesium ions within an organism or cell. [GOC:dph, GOC:tb]
Magnesium ion homeostasis is a tightly regulated process that maintains the appropriate concentration of magnesium ions (Mg2+) within cells and tissues. This process is essential for numerous cellular functions, including:
* **Enzyme activity:** Mg2+ serves as a cofactor for hundreds of enzymes involved in vital metabolic pathways, such as glycolysis, oxidative phosphorylation, DNA replication, and protein synthesis.
* **Cellular signaling:** Mg2+ plays a role in various signaling pathways, including those related to neuronal excitability, insulin signaling, and cell growth.
* **Structural integrity:** Mg2+ contributes to the structural integrity of ribosomes, nucleic acids, and cell membranes.
* **Muscle function:** Mg2+ is crucial for muscle contraction and relaxation, as it interacts with troponin and actin.
The regulation of magnesium ion homeostasis involves a complex interplay of several mechanisms:
* **Dietary intake:** The primary source of magnesium is dietary intake from food and beverages. The gastrointestinal tract absorbs magnesium, with the majority occurring in the small intestine. Factors influencing magnesium absorption include dietary intake, age, and vitamin D status.
* **Renal excretion:** The kidneys play a major role in regulating magnesium levels by filtering and reabsorbing it. When magnesium levels are high, the kidneys excrete excess magnesium in urine. When levels are low, the kidneys increase magnesium reabsorption.
* **Hormonal regulation:** Hormones such as parathyroid hormone (PTH), vitamin D, and aldosterone can influence magnesium levels. PTH stimulates renal magnesium reabsorption, while vitamin D promotes intestinal absorption. Aldosterone can increase magnesium excretion.
* **Cellular uptake and release:** Cells actively transport magnesium across their membranes using various transport proteins. These proteins regulate the intracellular magnesium concentration based on cellular needs.
Dysregulation of magnesium homeostasis can lead to various health problems. **Hypomagnesemia** (low magnesium levels) can cause muscle weakness, fatigue, seizures, arrhythmias, and other neurological disorders. **Hypermagnesemia** (high magnesium levels) can lead to muscle weakness, nausea, vomiting, and even coma in severe cases.
Maintaining adequate magnesium intake through diet and supplements, as well as addressing underlying medical conditions, is essential for ensuring proper magnesium homeostasis and overall health.'
"
Protein | Definition | Taxonomy |
---|---|---|
Potassium voltage-gated channel subfamily A member 1 | A voltage-gated potassium channel subunit KCNA1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q09470] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
4-aminopyridine | aminopyridine; aromatic amine | avicide; orphan drug; potassium channel blocker | |
N-(2-aminoethyl)-5-chloro-1-naphthalenesulfonamide | naphthalenes; sulfonic acid derivative | ||
5-methoxypsoralen | 5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5. 5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS. | 5-methoxyfurocoumarin; organic heterotricyclic compound; psoralens | hepatoprotective agent; plant metabolite |
flecainide | flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart). Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS. | aromatic ether; monocarboxylic acid amide; organofluorine compound; piperidines | anti-arrhythmia drug |
nifedipine | Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
tetraethylammonium | Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90) | quaternary ammonium ion | |
diltiazem | diltiazem : A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension. Diltiazem: A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions. | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
cortisone | 11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite | |
capsaicin | ALGRX-4975: an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief capsaicinoid : A family of aromatic fatty amides produced as secondary metabolites by chilli peppers. | capsaicinoid | non-narcotic analgesic; TRPV1 agonist; voltage-gated sodium channel blocker |
clathrodin | clathrodin: structure given in first source; isolated from marine sponges of the genus Agelas | ||
oroidin | oroidin: from marine sponges of the genus Agelas; structure in first source | pyrroles; secondary carboxamide | metabolite |
hymenidin | hymenidin: serotonergic receptor antagonist from Okinawan marine sponge Hymeniacidon; structure given in first source |